Dale Conover
Family · San Antonio, TXNPI 1568904852
Payments from drug & device makers
Across 142 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$598
- Novo Nordisk$385
- Amgen$321
- AbbVie$300
- Biohaven Pharmaceutical Holding Company Ltd.$259
- Acella Pharmaceuticals, LLC$168
- plus $858 from 18 others
What the payments were for
- Food & beverage$2,890100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 46 | $598 |
| Novo Nordisk | 18 | $385 |
| Amgen | 12 | $321 |
| AbbVie | 11 | $300 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $259 |
| Acella Pharmaceuticals, LLC | 8 | $168 |
| Esperion Therapeutics, Inc. | 2 | $132 |
| AstraZeneca | 1 | $120 |
| Pfizer | 6 | $105 |
| Exact Sciences | 5 | $81 |
| Corcept Therapeutics | 3 | $65 |
| Hologic Sales And Service, LLC | 2 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Antares Pharma, Inc. | 2 | $36 |
| IBSA Pharma Inc. | 2 | $30 |
| GSK | 1 | $24 |
| Philips North America LLC | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Halozyme Inc | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Shield Therapeutics Inc | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIMOVIG$125
- NURTEC ODT$125
- FARXIGA$120
- NEXLIZET$118
- NEXLETOL$118
How this compares
$2,890 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 15 | $974 |
| ProgesteroneProgesterone, Micronized | 14 | $503 |
| Liothyronine Sodium | 12 | $497 |
| Levothyroxine Sodium | 26 | $221 |
| Rosuvastatin Calcium | 22 | $209 |
| Bupropion XlBupropion Hcl | 12 | $166 |
| Montelukast Sodium | 11 | $161 |
| Anastrozole | 38 | $143 |
| Lisinopril | 30 | $122 |
| Atorvastatin Calcium | 20 | $119 |
| Escitalopram Oxalate | 14 | $101 |
| Tamsulosin Hcl | 11 | $96 |
| Amlodipine Besylate | 30 | $76 |
| Meloxicam | 21 | $36 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.